InsidersTradesSigma
Follow the CANDEL THERAPEUTICS INC share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: SESHU P TYAGARAJAN. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
CANDEL THERAPEUTICS INC is a company focused on developing innovative therapies for the treatment of serious diseases. It is listed on NASDAQ under the symbol XNAS.